X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12695) 12695
Publication (1581) 1581
Book Review (135) 135
Book Chapter (57) 57
Newspaper Article (48) 48
Conference Proceeding (31) 31
Magazine Article (25) 25
Book / eBook (17) 17
Dissertation (11) 11
Newsletter (8) 8
Streaming Video (8) 8
Trade Publication Article (4) 4
Reference (3) 3
Data Set (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (9242) 9242
index medicus (7232) 7232
male (6373) 6373
neurosciences (5504) 5504
rats (5324) 5324
humans (4517) 4517
brain (4344) 4344
female (3006) 3006
mice (2812) 2812
disease models, animal (2648) 2648
rats, sprague-dawley (2207) 2207
neurology (2080) 2080
rats, wistar (1711) 1711
oxidative stress (1671) 1671
clinical neurology (1635) 1635
neurons (1591) 1591
brain - drug effects (1553) 1553
brain - metabolism (1462) 1462
rodents (1377) 1377
analysis (1331) 1331
inflammation (1282) 1282
brain - pathology (1219) 1219
pharmacology & pharmacy (1191) 1191
time factors (1189) 1189
biochemistry & molecular biology (1142) 1142
apoptosis (1110) 1110
article (1098) 1098
mice, inbred c57bl (1087) 1087
hippocampus (1062) 1062
expression (1050) 1050
research (1049) 1049
central-nervous-system (1037) 1037
cell biology (1028) 1028
adult (1002) 1002
neurons - drug effects (1000) 1000
epilepsy (990) 990
seizures (929) 929
dose-response relationship, drug (908) 908
nervous system (897) 897
biomedicine (880) 880
rat-brain (838) 838
neurons - metabolism (837) 837
proteins (835) 835
immunohistochemistry (830) 830
hippocampus - drug effects (813) 813
neuroprotection (813) 813
cells, cultured (809) 809
physiological aspects (803) 803
middle aged (791) 791
rat (790) 790
stroke (771) 771
medicine (760) 760
research article (757) 757
animals, newborn (755) 755
health aspects (752) 752
ischemia (739) 739
gene expression (731) 731
alzheimers-disease (726) 726
neurodegeneration (724) 724
seizures - chemically induced (714) 714
neurotoxicity (698) 698
hippocampus - metabolism (693) 693
activation (680) 680
neurons - pathology (668) 668
hippocampus - pathology (660) 660
in-vivo (657) 657
multidisciplinary sciences (650) 650
toxicology (646) 646
injuries (627) 627
injury (624) 624
oxidative stress - drug effects (617) 617
microglia (608) 608
in-vitro (602) 602
neuroprotective agents - pharmacology (599) 599
risk factors (599) 599
pregnancy (596) 596
brain research (593) 593
care and treatment (591) 591
kainic acid (577) 577
immunology (575) 575
magnetic resonance imaging (573) 573
brain damage (566) 566
aged (563) 563
astrocytes (551) 551
psychiatry (551) 551
analysis of variance (545) 545
antioxidants (544) 544
brain - physiopathology (544) 544
physiology (544) 544
cytokines (536) 536
cells (533) 533
studies (517) 517
blood-brain barrier (516) 516
behavior, animal - drug effects (515) 515
science (513) 513
blood-brain-barrier (507) 507
brain injuries - chemically induced (501) 501
disease (499) 499
metabolism (489) 489
glutamate (482) 482
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (2) 2
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Searching (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12718) 12718
Japanese (52) 52
German (36) 36
Chinese (24) 24
French (22) 22
Russian (19) 19
Spanish (10) 10
Italian (7) 7
Norwegian (7) 7
Polish (4) 4
Dutch (3) 3
Swedish (3) 3
Danish (2) 2
Hungarian (2) 2
Lithuanian (2) 2
Portuguese (2) 2
Bulgarian (1) 1
Czech (1) 1
Hebrew (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2395 - 2410
Abstract Hydroxy-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors or statins are well tolerated, but associated with various statin-associated... 
Cardiovascular | Internal Medicine | rhabdomyolysis | skeletal muscle | interstitial lung disease | myopathy | C-REACTIVE PROTEIN | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | FORCE 2014 UPDATE | PRIMARY-PREVENTION TRIAL | INDUCED MUSCLE TOXICITY | INTERSTITIAL LUNG-DISEASE | CENTRAL-NERVOUS-SYSTEM | OF-THE-LITERATURE | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | Liver Function Tests | Sleep Wake Disorders - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - immunology | Myalgia - chemically induced | Humans | Hyperlipidemias - drug therapy | Risk Factors | Lung Diseases, Interstitial - chemically induced | Tendon Injuries - chemically induced | Necrosis - chemically induced | Brain - drug effects | Rupture - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Stroke - chemically induced | Cognition Disorders - etiology | Depression - chemically induced | Rhabdomyolysis - chemically induced | Antibodies - blood | Diabetes Mellitus - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Testosterone - blood | Autoimmune Diseases - chemically induced | Hyperlipidemias - complications | Viral antibodies | Complications and side effects | Enzymes | Thiols | Antibodies | Diabetes | Cardiology | Statins | Cardiovascular agents | Creatine kinase | Muscles | Creatine | Respiratory tract diseases | Studies | Musculoskeletal system | Genotype & phenotype | Mortality | Clinical trials | Lipids | Clinical medicine
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 09/2011, Volume 118, Issue 6, pp. 1032 - 1042
Journal Article
American Journal of Reproductive Immunology, ISSN 1046-7408, 05/2014, Volume 71, Issue 5, pp. 418 - 426
Problem Exposure to intrauterine inflammation, associated with preterm birth, has been linked to a devastating spectrum of neurobehavioral disorders.... 
mouse model | IL‐1 receptor antagonist | intrauterine inflammation | IL-1 receptor antagonist | Mouse model | Intrauterine inflammation | INTERLEUKIN-1 | REPRODUCTIVE BIOLOGY | ANTAGONIST | INFANTS | IMMUNOLOGY | CEREBRAL-PALSY | EXPRESSION | DAMAGE | Inflammation - chemically induced | Uterus - pathology | Inflammation - pathology | Premature Birth - genetics | Humans | Receptors, Interleukin-1 - genetics | Uterus - drug effects | Uterus - metabolism | Cerebral Cortex - pathology | Cerebral Cortex - metabolism | Lipopolysaccharides | Interleukin-1beta - metabolism | Premature Birth - chemically induced | Nitric Oxide Synthase Type I - antagonists & inhibitors | Female | Fetus | Cerebral Cortex - drug effects | Interleukin 1 Receptor Antagonist Protein - pharmacology | Infant, Newborn | Disease Models, Animal | Signal Transduction | Brain Injuries - chemically induced | Gene Expression Regulation | Brain Injuries - genetics | Brain Injuries - prevention & control | Receptors, Interleukin-1 - metabolism | Pregnancy | Premature Birth - pathology | Animals | Nitric Oxide Synthase Type I - metabolism | Inflammation - genetics | Inflammation - prevention & control | Mice | Nitric Oxide Synthase Type I - genetics | Receptors, Interleukin-1 - antagonists & inhibitors | Brain Injuries - pathology | Brain damage | Neurotoxicity | Premature birth | Nitric oxide | Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 06/2010, Volume 30, Issue 24, pp. 8285 - 8295
Toll-like receptors play an important role in the innate immune response, although emerging evidence indicates their role in brain injury and... 
ETHANOL TREATMENT | ALZHEIMERS-DISEASE | IN-VIVO | TOLL-LIKE RECEPTORS | INJURY | NEURODEGENERATION | ENHANCES INFLAMMATORY MEDIATORS | ASTROGLIAL CELLS | ASTROCYTES | NEUROSCIENCES | CELL-DEATH | Tumor Necrosis Factor-alpha - metabolism | Rats, Wistar | Lymphocyte Antigen 96 - metabolism | Tumor Necrosis Factor-alpha - genetics | Caspase 3 - metabolism | Ethanol - administration & dosage | Green Fluorescent Proteins - genetics | Brain Injuries - metabolism | Interleukin-1beta - genetics | Lipopolysaccharides - adverse effects | Lipopolysaccharide Receptors - metabolism | Lymphocyte Antigen 96 - genetics | Ethanol - blood | Time Factors | Toll-Like Receptor 4 - deficiency | Cyclooxygenase 2 - genetics | Interleukin-1beta - metabolism | Encephalitis - metabolism | Statistics, Nonparametric | Brain Injuries - blood | Female | Disease Models, Animal | Calcium-Binding Proteins - metabolism | Astrocytes - drug effects | Mice, Inbred C57BL | RNA, Messenger - genetics | RNA, Small Interfering - pharmacology | Brain Injuries - chemically induced | Encephalitis - pathology | Rats | Mice, Knockout | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Toll-Like Receptor 4 - physiology | Animals | Microfilament Proteins | Central Nervous System Depressants - administration & dosage | Cyclooxygenase 2 - metabolism | Mice | Encephalitis - chemically induced | Central Nervous System Depressants - blood | Brain Injuries - pathology | Encephalitis - blood | Astrocytes - metabolism | Calcium-Binding Proteins - genetics
Journal Article
Neuropharmacology, ISSN 0028-3908, 2011, Volume 61, Issue 5, pp. 975 - 980
Thrombin activates immunocompetent microglia and increases release of inflammatory cytokines under intracerebral hemorrhage (ICH) insults. Also, thrombin... 
Glycyrrhizin | Thrombin | High-mobility group box 1 | Intracerebral hemorrhage | MICROGLIAL ACTIVATION | CYTOKINE | BLOOD-BRAIN-BARRIER | NEUROSCIENCES | GROUP BOX-1 PROTEIN | SLICE CULTURES | CHROMATIN PROTEIN | EDEMA | IN-VIVO | PROTEIN-KINASE PATHWAYS | PHARMACOLOGY & PHARMACY | Rats, Wistar | Brain Injuries - complications | Hemostatics - pharmacology | Male | Molecular Targeted Therapy | Anti-Inflammatory Agents - metabolism | Corpus Striatum - metabolism | Nitric Oxide - analysis | Cerebral Cortex - metabolism | Brain - metabolism | Glycyrrhizic Acid - pharmacology | Thrombin - pharmacology | Neostriatum - drug effects | Cattle | Anti-Inflammatory Agents - therapeutic use | Behavior, Animal - drug effects | Neostriatum - metabolism | Neurons - metabolism | Cell Death - drug effects | Cerebral Cortex - drug effects | Drug Evaluation, Preclinical | HMGB1 Protein - physiology | Neurons - drug effects | Corpus Striatum - pathology | HMGB1 Protein - antagonists & inhibitors | Cerebral Hemorrhage - chemically induced | Nitric Oxide - biosynthesis | Cerebral Hemorrhage - drug therapy | Brain Edema - metabolism | Anti-Inflammatory Agents - pharmacology | Tissue Culture Techniques | Brain Edema - pathology | Brain Injuries - chemically induced | Glycyrrhizic Acid - metabolism | Rats | Behavior, Animal - physiology | Collagenases - physiology | Rats, Sprague-Dawley | Brain - drug effects | Glycyrrhizic Acid - therapeutic use | Animals | Brain Edema - chemically induced | Cell Death - physiology | Corpus Striatum - drug effects | Brain Edema - drug therapy | Brain Injuries - pathology | Cerebral Hemorrhage - pathology | Methyl aspartate | Chromosomal proteins | Corticosteroids | Neurons | Nitric oxide | Dimethyl sulfoxide | Fluorescence | Universities and colleges | Protein kinases
Journal Article
Epilepsia, ISSN 0013-9580, 08/2013, Volume 54, Issue 4, pp. 44 - 60
Summary Many symptoms of neurologic or psychiatric illness—such as cognitive impairment, depression, anxiety, attention deficits, and migraine—occur more... 
Biomarkers | Therapy | Animal models | Comorbidity | Epilepsy | DEPRESSIVE-LIKE BEHAVIOR | TEMPORAL-LOBE EPILEPSY | GENETIC ABSENCE EPILEPSY | ENVIRONMENTAL ENRICHMENT | KETOGENIC DIET | CLINICAL NEUROLOGY | TRAUMATIC BRAIN-INJURY | EARLY-LIFE SEIZURES | SPATIAL MEMORY | INDUCED STATUS EPILEPTICUS | IMMATURE RATS | Drugs, Investigational - adverse effects | Cognition Disorders - chemically induced | Humans | Drugs, Investigational - therapeutic use | Depressive Disorder - drug therapy | Neurocognitive Disorders - psychology | Anxiety Disorders - chemically induced | Migraine Disorders - chemically induced | Neurocognitive Disorders - drug therapy | Depressive Disorder - chemically induced | Quality of Life - psychology | Anxiety Disorders - drug therapy | Drug Evaluation, Preclinical | Cognition Disorders - psychology | Disease Models, Animal | Attention Deficit Disorder with Hyperactivity - chemically induced | Epilepsy - psychology | Translational Medical Research | Neurocognitive Disorders - diagnosis | Neurocognitive Disorders - chemically induced | Cognition Disorders - drug therapy | Anxiety Disorders - psychology | Attention Deficit Disorder with Hyperactivity - drug therapy | Drug Discovery | Migraine Disorders - drug therapy | Epilepsy - diagnosis | Cognition Disorders - diagnosis | Animals | Migraine Disorders - psychology | Attention Deficit Disorder with Hyperactivity - psychology | Epilepsy - drug therapy | Depressive Disorder - psychology | Analysis | Medical research | Quality of life
Journal Article